AI Article Synopsis
- Invasive candidiasis (IC) is a major concern in hospitals, often difficult to diagnose due to limitations in blood culture methods.
- A study evaluated the effectiveness of the FungiXpert® BDG Detection Kit for diagnosing IC, showing it had a sensitivity of 60.52% and specificity of 81.81% among 80 patients tested.
- Results indicated that higher BDG levels correlated with more severe outcomes, suggesting the kit could be useful for diagnosis, especially in resource-limited settings.
Article Abstract
Background And Purpose: Invasive candidiasis (IC) in the hospitalized population is one of the leading causes of invasive fungal infections (IFIs). Microbiological diagnosis of IC suffers due to poor sensitivity of blood culture and relative inaccessibility to more sensitive modalities. (1, 3)-β-D-glucan (BDG) is a cell wall polysaccharide found in a range of fungi. Various commercial assays are available based on various detection techniques. This study aimed to assess the diagnostic performance of the FungiXpert® Fungus BDG Detection Kit by Genobio Pharmaceutical Co. Ltd. (Tianjin, China), based on chemiluminescent method, for diagnosis of candidemia and deep-seated candidiasis.
Materials And Methods: In total, 80 patients (34 males and 46 females) were included with a median age of 35 years old. In accordance with EORTC/MSGERC definitions, 39 patients had proven IC. The number of patients within the probable, possible, and no IC (taken as control) groups were 8, 4, and 29, respectively. Blood samples were collected for fungal blood culture and BDG assay.
Results: After exclusion of cases with evidence of concurrent IFI other than IC, median serum BDG was 0.63 ng/ml for proven IC; while it was 0.04 ng/ml for NO IC. Sensitivity, specificity, positive, and negative predictive values were 60.52%, 81.81%, 85.18%, and 54.54%, respectively. Positive likelihood ratio was 3.32. While the assay performed best for with median BDG of 1.92 ng/ml and sensitivity of 92.3%, its performance was worst for , with median BDG of 0.04 ng/ml and sensitivity of 44.44%. Overall mortality rate was 65.62% in the BDG positive group, which was significantly higher than that in the BDG negative group (33.33%).
Conclusion: The performance of the FungiXpert® Fungus BDG Detection Kit was acceptable for invasive candidiasis in the present resource-limited setup. The major advantages of this assay were the ease of performance in a semi-automated cartridge format, relatively lower cost per test, non-reliance on glucan-free procedures or instruments and minimal hands-on procedure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688587 | PMC |
| http://dx.doi.org/10.22034/cmm.2024.345199.1513 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An overview of healthcare-associated Candida auris outbreaks in Ministry of Health hospitals-Saudi Arabia 2020-2022; Retrospective multicentric study.
PLoS One
January 2025
General Directorate of Infection Prevention & Control, Ministry of Health-Saudi Arabia, Riyadh, Saudi Arabia.
Background: Candida auris (C. auris) is an emerging fungus pathogen associated with nosocomial infections that is seen as a serious global health issue.
Aim: To describe the epidemiology and features of hospital-acquired Candida auris outbreaks in the Ministry of Health hospitals (MOH).
A Narrative Review of Invasive Candidiasis in the Intensive Care Unit.
Ther Adv Pulm Crit Care Med
December 2024
Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization, (MICRO), St James' Hospital, Dublin, Ireland.
species is the most common cause of invasive fungal infection in the critically ill population admitted to the intensive care unit (ICU). Numerous risk factors for developing invasive candidiasis (IC) have been identified, and some, like the breach of protective barriers, abound within the ICU. Given that IC carries a significant mortality, morbidity, and healthcare cost burden, early diagnosis and treatment have become an essential topic of discussion.
View Article and Find Full Text PDFThe (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: a prospective cohort study.
Tunis Med
December 2024
University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta Tertiary Hospital, Intensive Care Medicine Department, 1007, Tunis, Tunisia.
Unlabelled: Introduction Invasive candidiasis (IC) is a widespread infection in intensive care. As culture-based diagnostic techniques take several days before positivity and leaks of sensitivity. (1,3)-β-D-glucan (BDG) was proposed as a mycological criterion for IC diagnosis in selected patients.
View Article and Find Full Text PDFEarly Diagnosis of Candidemia in the Intensive Care Unit by Clinical and Molecular Methods: A Prospective Observational Study.
Infect Dis Clin Microbiol
December 2024
Department of Infectious Diseases and Clinical Microbiology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Türkiye.
Objective: Early diagnosis and treatment of candidemia in intensive care units (ICUs) remain a significant challenge globally because of the lack of well-established non-culture-based diagnostic methods. This study aimed to evaluate risk factors in critically ill ICU patients, develop a unique score, and create a real-time polymerase chain reaction (PCR) assay for the early diagnosis of candidemia.
Materials And Methods: The study was conducted in three phases: 1) Retrospective analysis of 100 ICU patients from İstanbul University-Cerrahpaşa between January 2017 and December 2018 to identify risk factors for invasive candidiasis, 2) development of Cerrahpaşa score based on these findings, and 3) prospective evaluation of 75 ICU patients, applying the newly created Cerrahpaşa score and implementing a rapid PCR-based test on whole blood samples.
Evaluation of a newer (1, 3)-β-D-glucan chemiluminescent immunoassay for invasive candidiasis: A study from a tertiary care center.
Curr Med Mycol
May 2024
Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Article Synopsis
- Invasive candidiasis (IC) is a major concern in hospitals, often difficult to diagnose due to limitations in blood culture methods.
- A study evaluated the effectiveness of the FungiXpert® BDG Detection Kit for diagnosing IC, showing it had a sensitivity of 60.52% and specificity of 81.81% among 80 patients tested.
- Results indicated that higher BDG levels correlated with more severe outcomes, suggesting the kit could be useful for diagnosis, especially in resource-limited settings.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!